The invention is directed to 5,6-dihydro-1H-pyridin-2-one compounds and pharmaceutical compositions containing such compounds that are useful in treating infections by hepatitis C virus.
The invention is directed to 5,6-dihydro-1H-pyridin-2-one compounds of Formula I
wherein
X is N, and
A is
and compounds used to synthesize the compounds of Formula I.